Shares of CME Group Inc (NASDAQ:CME) have earned an average recommendation of “Buy” from the thirteen ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $141.75.

CME has been the subject of a number of recent analyst reports. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, September 27th. Barclays boosted their price target on shares of CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research report on Tuesday, October 10th. UBS restated a “buy” rating and set a $135.00 price target (up from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. Royal Bank Of Canada boosted their price target on shares of CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $127.00 target price on shares of CME Group in a research report on Friday, August 18th.

CME Group (NASDAQ:CME) traded up $1.25 during trading on Friday, reaching $150.79. 2,800,000 shares of the company were exchanged, compared to its average volume of 1,240,000. The stock has a market cap of $51,310.00, a price-to-earnings ratio of 30.36, a price-to-earnings-growth ratio of 2.98 and a beta of 0.71. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. CME Group has a fifty-two week low of $113.00 and a fifty-two week high of $152.14.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. The firm had revenue of $890.80 million during the quarter, compared to analyst estimates of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.05 EPS. equities research analysts anticipate that CME Group will post 4.78 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Shareholders of record on Friday, December 8th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 1.75%. The ex-dividend date of this dividend is Thursday, December 7th. CME Group’s dividend payout ratio is presently 59.86%.

In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction on Wednesday, October 11th. The shares were sold at an average price of $136.83, for a total value of $342,075.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 2,600 shares of the business’s stock in a transaction on Friday, November 17th. The stock was sold at an average price of $139.57, for a total transaction of $362,882.00. Following the completion of the sale, the insider now directly owns 22,301 shares of the company’s stock, valued at $3,112,550.57. The disclosure for this sale can be found here. Insiders sold 27,510 shares of company stock valued at $3,889,604 over the last three months. 0.57% of the stock is currently owned by insiders.

Institutional investors have recently bought and sold shares of the business. Fiduciary Trust Co. bought a new position in shares of CME Group during the second quarter valued at about $105,000. Quadrant Capital Group LLC raised its stake in shares of CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after acquiring an additional 113 shares during the last quarter. Valeo Financial Advisors LLC bought a new position in shares of CME Group during the third quarter valued at about $124,000. San Francisco Sentry Investment Group CA bought a new position in shares of CME Group during the second quarter valued at about $129,000. Finally, People s United Financial Inc. raised its stake in shares of CME Group by 11.5% during the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 110 shares during the last quarter. 83.08% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “CME Group Inc (CME) Given Average Rating of “Buy” by Analysts” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/12/01/cme-group-inc-cme-given-average-rating-of-buy-by-analysts.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.